September 19, 2014
IDIBAPS has reformed the installations at Còrsega Street with funds of the Astra Zeneca Chair in Diabetes Innovation
The Astra Zeneca Chair in Diabetes Innovation has funded the refurbishment of the IDIBAPS facilities at 180 Còrsega Street to adapt some of the areas for translational research related to the improvement of the clinical practice. Several of the activities of Dr. Emili Ros, Dr. Josep Vidal and Dr. Anna Novials research teams are located in these facilities, although they are open and accessible to all groups at IDIBAPS.
September 1, 2014
Genetic and environmental factors play an important role in the susceptibility of developing colon cancer (CRC). In an article published in the journal Genetics in Medicine scientists have identified six genes that had not been associated with this type of cancer before. The study has been conducted by Dr. Sergi Castellví-Bel, member of the team Gastrointestinal and Pancreatic Oncology at IDIBAPS. Predoctoral researcher Clara Esteban-Jurado is the first author of the work.
July 31, 2014
According to an article published in PLoSOne, researchers from IDIBAPS reconstitute a new nasal respiratory epithelium from mature stem cells of the nasal mucosa of both healthy and inflamed tissue. They have met their objectives by using a technique based in the exposure of primary culture cells to the air.
July 25, 2014
Euroimmun acquires the rights of a patent developed by Dr. Graus and Dr. Dalmau for the diagnosis of autoimmune diseases
Dr. Graus and Dr. Dalmau have developed a technology for the diagnosis, prognosis and treatment of patients with an autoimmune disease associated to sleep disorders. It is based on detecting the presence of antibodies against the neuronal protein IGLON5 by immunocytochemistry of transfected cells.
July 18, 2014
The report named "Spanish Participation in the Innovative Medicines Initiative (IMI)" has been recently published by the Center for Industrial Technological Development (CDTI). This report lists the main indicators of participation in 8 of the 11 IMI’s calls supported under the 7th Framework Programme.